Graybill Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$318K Hold
4,061
0.09% 71
2026
Q1
$352K Hold
4,061
0.11% 69
2025
Q4
$390K Hold
4,061
0.12% 68
2025
Q3
$387K Hold
4,061
0.12% 67
2025
Q2
$354K Sell
4,061
-100
-2% -$8.48K 0.12% 71
2025
Q1
$374K Buy
+4,161
New +$372K 0.13% 66

Other funds holding MDT

Graybill Wealth Management's MDT Position: Q2 2026 in Review

Graybill Wealth Management held its Medtronic (MDT) position steady in Q2 2026 at 4,061 shares worth $318K. The position accounts for 0.09% of the portfolio, ranked #71.

Graybill Wealth Management first reported a position in MDT in Q1 2025 and has held it in 6 quarters since. The position peaked at $390K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Graybill Wealth Management held 4,061 shares of Medtronic worth $318K as of Q2 2026.
  • Graybill Wealth Management left its Medtronic share count unchanged in Q2 2026.
  • Medtronic made up 0.09% of Graybill Wealth Management's portfolio in Q2 2026, its #71 holding.
  • Graybill Wealth Management first reported a position in Medtronic in Q1 2025 and has held it in 6 quarters since.
  • Graybill Wealth Management's Medtronic position peaked at $390K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Graybill Wealth Management's 13F filing for Q2 2026, filed 17 Aug 2026.